Jasper Therapeutics (JSPR) Research & Development (2020 - 2025)
Jasper Therapeutics' Research & Development was $11.36 million in Q4 2025, down 42.5% from $19.77 million a year earlier and down 21.1% from the prior quarter.
Powered by 
Analysis
Jasper Therapeutics (JSPR) Research & Development (2020 - 2025) Analysis & Trends
For FY2025, Research & Development at Jasper Therapeutics came in at $63.1 million, up 13.0% from FY2024.
- Research & Development has now increased for five consecutive years, with a five-year compound annual growth rate of 31.8% (FY2020 to FY2025).
- In earlier years, Research & Development was $55.82 million in FY2024 (+7.8%), $51.79 million in FY2023 (+49.6%), $34.63 million in FY2022 (+36.2%) and $25.42 million in FY2021 (+60.1%).
- The Q4 2025 figure marks the lowest quarterly Research & Development since Q2 2024.
- Compared with a year earlier, Research & Development was higher in four of the last eight quarters, with growth averaging 16.5%.
- The best year-over-year quarter for Research & Development over five years was Q2 2025 (growth of 87.6%); the worst was Q4 2022 (a decline of 90.3%).
- Per Business Quant data, JSPR's Research & Development in the three quarters before Q4 2025 was $14.39 million (Q3 2025), $21.2 million (Q2 2025) and $16.16 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Jasper Therapeutics | 14.34 Mn | -112.08 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 11.36 Mn |
| Sep 30, 2025 | 14.39 Mn |
| Jun 30, 2025 | 21.20 Mn |
| Mar 31, 2025 | 16.16 Mn |
| Dec 31, 2024 | 19.77 Mn |
| Sep 30, 2024 | 14.46 Mn |
| Jun 30, 2024 | 11.30 Mn |
| Mar 31, 2024 | 10.30 Mn |
| Dec 31, 2023 | 13.84 Mn |
| Sep 30, 2023 | 14.85 Mn |
| Jun 30, 2023 | 13.30 Mn |
| Mar 31, 2023 | 9.81 Mn |
| Dec 31, 2022 | 842,000.00 |
| Sep 30, 2022 | 9.02 Mn |
| Jun 30, 2022 | 8.14 Mn |
| Mar 31, 2022 | 8.19 Mn |
| Dec 31, 2021 | 8.66 Mn |
| Sep 30, 2021 | 7.19 Mn |
| Jun 30, 2021 | 5.16 Mn |
| Mar 31, 2021 | 4.42 Mn |
API Access
Jasper Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=JSPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "JSPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=JSPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();